Intrepid Financial Planning Group LLC Reduces Stake in GE HealthCare Technologies Inc. $GEHC

Intrepid Financial Planning Group LLC lessened its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 25.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,110 shares of the company’s stock after selling 2,793 shares during the quarter. Intrepid Financial Planning Group LLC’s holdings in GE HealthCare Technologies were worth $601,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. TD Waterhouse Canada Inc. increased its stake in shares of GE HealthCare Technologies by 11.3% in the second quarter. TD Waterhouse Canada Inc. now owns 502,645 shares of the company’s stock worth $38,145,000 after acquiring an additional 50,841 shares during the period. PFG Private Wealth Management LLC boosted its holdings in GE HealthCare Technologies by 7.2% in the second quarter. PFG Private Wealth Management LLC now owns 2,771 shares of the company’s stock valued at $205,000 after purchasing an additional 186 shares during the last quarter. Vanguard Group Inc. grew its position in GE HealthCare Technologies by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares during the period. Chiron Capital Management LLC purchased a new position in shares of GE HealthCare Technologies during the 2nd quarter valued at about $285,000. Finally, Nomura Asset Management Co. Ltd. raised its stake in shares of GE HealthCare Technologies by 5.6% during the 2nd quarter. Nomura Asset Management Co. Ltd. now owns 169,092 shares of the company’s stock valued at $12,525,000 after buying an additional 8,998 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Evercore ISI upped their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. BTIG Research set a $87.00 target price on shares of GE HealthCare Technologies in a report on Wednesday, October 29th. Wells Fargo & Company decreased their target price on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Stock Performance

GEHC opened at $71.02 on Wednesday. The firm’s fifty day simple moving average is $74.84 and its two-hundred day simple moving average is $73.77. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a market cap of $32.35 billion, a price-to-earnings ratio of 14.67, a PEG ratio of 2.65 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period last year, the firm posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 14th. Shareholders of record on Friday, October 24th were paid a dividend of $0.035 per share. The ex-dividend date of this dividend was Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.